Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(0.84)
# 3,929
Out of 5,182 analysts
181
Total ratings
21.88%
Success rate
-10.55%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.38 | +552.17% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.23 | +16,160.16% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.83 | +293.37% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.21 | +230.58% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.62 | +7,533.59% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.22 | +755.86% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $5.52 | +280.43% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $0.65 | +2,224.14% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.17 | +25,706.45% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $1.96 | +6,013.09% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.68 | +498.80% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $5.95 | +1,412.61% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.12 | +133.99% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.10 | +416.13% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.89 | +573.55% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.81 | +12,322.36% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $2.92 | +1,849,215.07% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.55 | +684.31% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.80 | +328,025.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $8.33 | +5,902.40% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $36.56 | +556.46% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.91 | +8,691.21% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $14.43 | +55,359.27% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.67 | +319.16% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.30 | +2,207.69% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.49 | +1,046.13% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.07 | +342.26% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.30 | +117.39% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $65.01 | -63.08% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.74 | +461,438.46% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.83 | +2,302,651.18% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.38
Upside: +552.17%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.23
Upside: +16,160.16%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.83
Upside: +293.37%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.21
Upside: +230.58%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.62
Upside: +7,533.59%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.22
Upside: +755.86%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $5.52
Upside: +280.43%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.65
Upside: +2,224.14%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.17
Upside: +25,706.45%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $1.96
Upside: +6,013.09%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $6.68
Upside: +498.80%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $5.95
Upside: +1,412.61%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.12
Upside: +133.99%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.10
Upside: +416.13%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.89
Upside: +573.55%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.81
Upside: +12,322.36%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $2.92
Upside: +1,849,215.07%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.55
Upside: +684.31%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.80
Upside: +328,025.00%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $8.33
Upside: +5,902.40%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $36.56
Upside: +556.46%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.91
Upside: +8,691.21%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $14.43
Upside: +55,359.27%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.67
Upside: +319.16%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.30
Upside: +2,207.69%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $3.49
Upside: +1,046.13%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $4.07
Upside: +342.26%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.30
Upside: +117.39%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $65.01
Upside: -63.08%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.74
Upside: +461,438.46%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.83
Upside: +2,302,651.18%